Bioprocessing is a significant part of biopharmaceutical development and production processes and single-use bioprocessing systems, which are meant for one-time use, have recently found their unique position in the biopharmaceutical and bio therapeutics industry. Disposable bioprocessing process in which the systems such as disposable bioreactor, single-use bags, and disposable filters are disposed after use instead of cleaning or sterilization. Single-use systems are majorly adapted in upstream and downstream bioprocessing, owing to its benefits over conventional bioprocessing systems, which includes reduction of cost, increased speed of implementation, and reduced risk of cross-contamination.
The market of single-use bioprocessing systems is anticipated to grow with a significant rate in the coming years, owing to factors such as, Rise in the adoption of single-use technologies for continuous manufacturing, Lower risk of cross-contamination and reduced manufacturing costs are the factors primed to drive the single-use bioprocessing systems market. On other hand increase in focus toward mergers, acquisitions, and product launches offer lucrative opportunities for the expansion of the global single-use bioprocessing market
The "Global Single-Use Bioprocessing Systems Market Analysis to 2028" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of the global single-use bioprocessing systems market with detailed market segmentation by product, application, end user, and geography. The global single-use bioprocessing systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
The global single-use bioprocessing systems market is segmented on the basis of product, application, and end user. The product segment includes, bioreactors, mixers, bags, tubing, filtration devices, bioprocess containers, sampling systems, and probes & sensors. On the application basis the single-use bioprocessing systems market is segmented as monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and other application. Based on end users, monoclonal antibody production, vaccine production, plant cell cultivation, patient specific cell therapies, and other end users.
The single-use bioprocessing systems market report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global single-use bioprocessing systems market based on product, application, and end user. It also provides market size and forecast till 2028 for overall single-use bioprocessing systems market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The single-use bioprocessing systems market report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
North America holds the dominant position in the single-use bioprocessing systems market, owing to quick adoption of technological advance products and approval of the foam dressing kits for combinational therapy by the U.S FDA is expected to propel market growth in the region. On other hand, the Asia-Pacific region is expected to witness significant growth during the forecast period, with the majority of growth primarily driven by rise in the adoption of single-use technologies for continuous manufacturing, and growth of biotech start-ups and greater influx of contract manufacturers in the emerging economies.
The single-use bioprocessing systems market report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The single-use bioprocessing systems market report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The single-use bioprocessing systems report also includes the profiles of key single-use bioprocessing systems manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Danaher, Finesse, General Electric Company, PARKER HANNIFIN CORP, PBS Biotech, Inc., 3M, Applikon Biotechnology, Eppendorf AG., MEISSNER FILTRATION PRODUCTS, INC., and Sentinel Process Systems Inc. among others.
TABLE OF CONTENTS
LIST OF TABLES
LIST OF FIGURES
The List of Companies
1. Danaher
2. Finesse
3. General Electric Company
4. PARKER HANNIFIN CORP
5. PBS Biotech, Inc.
6. 3M
7. Applikon Biotechnology
8. Eppendorf AG.
9. MEISSNER FILTRATION PRODUCTS, INC.
10. Sentinel Process Systems Inc.